Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Advanced Solid Tumours 2Vaginal Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Previously Treated Non Small Cell Lung Cancer 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Endometrioid 1Blast Crisis 1Advanced Solid Tumors 1

Interventions

durvalumab 2tremelimumab 1rocakinogene sifuplasmid 1adavosertib 1VGX-3100 1Radiotherapy 1Radiation 1Platinum 1Palliative Care 1MEDI0457 1Immunoglobulin G 1Disulfides 1Device Removal 1Congresses as Topic 1Cisplatin 1Axitinib 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vaginal Neoplasms × adavosertib × Clear all
NCT03345784 2024-02-20

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

National Cancer Institute (NCI)

Phase 1 Terminated
10 enrolled 15 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡